Director/PDMR Shareholding

RNS Number : 7028F
Smith & Nephew Plc
19 July 2021
 

 

SMITH & NEPHEW PLC

 

19 July 2021

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

On 16 July 2021, Smith & Nephew plc (the "Company") received notification of the following transactions as detailed below.

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc SPON ADR American Depositary Shares (ADS)

 

 

Identification code

ISIN: US83175M2052

Nature of the transaction

Purchase of American Depository Shares as participants of the Company's Employee Stock Purchase Plan.

Date of Transaction

2021 - 07 - 13

Place of Transaction

New York Stock Exchange

 

Name

Director / PDMR

Price ($)

Volume

Aggregated information

Total Ordinary Share Holding following the transaction *

Total Ordinary Share Holding as a % of the Company's ISC following the transaction *

Bradley Cannon

(President Sports Medicine & ENT)

PDMR

36.52

290.9006

N/A Single Transaction

77,921.38984 (including 2,414.63870 in ADS')

0.00880%

Catheryn O'Rourke

(Chief Legal & Compliance Officer)

 

PDMR

36.52

290.9006

N/A Single Transaction

82,804.67869 (including 6,170.31995 in ADS')

0.00936%

 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

 

Vickie Reuben  

Deputy Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477410

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFELDTIALIL
UK 100

Latest directors dealings